Literature DB >> 21908388

68Ga PET/CT ventilation-perfusion imaging for pulmonary embolism: a pilot study with comparison to conventional scintigraphy.

Michael S Hofman1, Jean-Mathieu Beauregard, Thomas W Barber, Oliver C Neels, Peter Eu, Rodney J Hicks.   

Abstract

UNLABELLED: Ventilation-perfusion (V/Q) scintigraphy is established for regional assessment of lung function in a variety of diseases, including pulmonary embolism (PE). PET/CT may further improve the accuracy and utility of V/Q imaging because of its superior technical characteristics. This pilot study assessed the feasibility of performing V/Q PET/CT and compared diagnostic utility with conventional V/Q imaging in patients with clinical suspicion of PE.
METHODS: Ten patients undergoing conventional V/Q imaging were prospectively recruited. PET/CT V/Q imaging was performed after inhalation of (68)Ga-carbon nanoparticles ("Galligas") and administration of (68)Ga-macroaggregated albumin. Blinded to the results of the other study, SPECT/CT (n = 9) or SPECT (n = 1) images and PET/CT images were graded by a predefined scoring system for scan quality. The number of matched or unmatched defects and diagnosis were also measured and compared with a final diagnosis.
RESULTS: PET image quality was equivalent or superior to SPECT in all patients, with more homogeneous radiotracer distribution for both ventilation and perfusion studies (P < 0.01). Based on conventional V/Q imaging, the diagnosis was acute PE in 2 patients and no PE in 7 patients, and the imaging results were nondiagnostic in 1 patient. The PET/CT diagnosis was concordant in 8 patients, and these studies demonstrated a similar number and distribution of matched and unmatched defects. In 1 discordant case, a patient with a SPECT/CT study that was nondiagnostic because of severe airway disease showed no PE on PET/CT. In another, the diagnosis of PE established on SPECT/CT was not reported on PET/CT 2 d later, possibly because of interval clot lysis or migration.
CONCLUSION: This intraindividual comparative study demonstrated that V/Q PET/CT with (68)Ga-labeled radiotracers can be performed in clinical practice. Compared with conventional V/Q imaging, advantages include higher-resolution, fully tomographic images with potentially better regional quantitation of lung function. The short half-life of (68)Ga also enables more flexible acquisition protocols with the option of performing ventilation studies selectively on patients with abnormal perfusion. On the basis of our results, further studies are indicated to assess whether V/Q PET/CT can improve diagnostic algorithms for patients with suspected PE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21908388     DOI: 10.2967/jnumed.111.093344

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  22 in total

1.  The VAMPIRE challenge: A multi-institutional validation study of CT ventilation imaging.

Authors:  John Kipritidis; Bilal A Tahir; Guillaume Cazoulat; Michael S Hofman; Shankar Siva; Jason Callahan; Nicholas Hardcastle; Tokihiro Yamamoto; Gary E Christensen; Joseph M Reinhardt; Noriyuki Kadoya; Taylor J Patton; Sarah E Gerard; Isabella Duarte; Ben Archibald-Heeren; Mikel Byrne; Rick Sims; Scott Ramsay; Jeremy T Booth; Enid Eslick; Fiona Hegi-Johnson; Henry C Woodruff; Rob H Ireland; Jim M Wild; Jing Cai; John E Bayouth; Kristy Brock; Paul J Keall
Journal:  Med Phys       Date:  2019-02-01       Impact factor: 4.071

Review 2.  Is there still a role for SPECT-CT in oncology in the PET-CT era?

Authors:  Rodney J Hicks; Michael S Hofman
Journal:  Nat Rev Clin Oncol       Date:  2012-11-13       Impact factor: 66.675

Review 3.  Nanoparticles labeled with positron emitting nuclides: advantages, methods, and applications.

Authors:  Yongjian Liu; Michael J Welch
Journal:  Bioconjug Chem       Date:  2012-02-06       Impact factor: 4.774

4.  68Ga-Labelled Carbon Nanoparticles for Ventilation PET/CT Imaging: Physical Properties Study and Comparison with Technegas®.

Authors:  Frédérique Blanc-Béguin; Philippe Eliès; Philippe Robin; Raphaël Tripier; Nelly Kervarec; Catherine A Lemarié; Simon Hennebicq; Cécile Tromeur; Virginie Cogulet; Pierre-Yves Salaün; Pierre-Yves Le Roux
Journal:  Mol Imaging Biol       Date:  2020-09-04       Impact factor: 3.488

5.  Independent and incremental value of ventilation/perfusion PET/CT and CT pulmonary angiography for pulmonary embolism diagnosis: results of the PECAN pilot study.

Authors:  Pierre-Yves Le Roux; Amir Iravani; Jason Callahan; Kate Burbury; Peter Eu; Daniel P Steinfort; Eddie Lau; Beverly Woon; Pierre-Yves Salaun; Rodney J Hicks; Michael S Hofman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-05-01       Impact factor: 9.236

Review 6.  Radiopharmaceutical Labelling for Lung Ventilation/Perfusion PET/CT Imaging: A Review of Production and Optimization Processes for Clinical Use.

Authors:  Frédérique Blanc-Béguin; Simon Hennebicq; Philippe Robin; Raphaël Tripier; Pierre-Yves Salaün; Pierre-Yves Le Roux
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-22

7.  High-resolution imaging of pulmonary ventilation and perfusion with 68Ga-VQ respiratory gated (4-D) PET/CT.

Authors:  Jason Callahan; Michael S Hofman; Shankar Siva; Tomas Kron; Michal E Schneider; David Binns; Peter Eu; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-06       Impact factor: 9.236

Review 8.  State-of-the-Art Imaging for the Evaluation of Pulmonary Embolism.

Authors:  Leonid Roshkovan; Harold Litt
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-08-07

9.  Combined Assessment of Pulmonary Ventilation and Perfusion with Single-Energy Computed Tomography and Image Processing.

Authors:  Yukio Fujita; Michael Kent; Erik Wisner; Lynelle Johnson; Joshua Stern; Lihong Qi; John Boone; Tokihiro Yamamoto
Journal:  Acad Radiol       Date:  2020-06-10       Impact factor: 3.173

10.  Ga-68 EDTA aerosols in evaluation of inhaled-particle deposition and clearance of obstructive pulmonary diseases: A pilot prospective study compared with Galligas.

Authors:  Shao-Ting Wang; Cheng Bao; Qingxing Liu; Tengyue Zhang; Yanli Yang; Xinlun Tian; Zhaohui Zhu; Kai-Feng Xu
Journal:  Eur J Clin Invest       Date:  2021-06-02       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.